Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at fjernelse af thiomersal fra vacciner ikke reducerede deres effektivitet med hensyn til at beskytte imod infektion med hepatitis B - virus, men reducerede risiciene.
The Committee for Medicinal Products for Human Use (CHMP) concluded that the removal of thiomersal from vaccines did not reduce their effectiveness in protecting against hepatitis B virus infection, but reduced their risks.